92 related articles for article (PubMed ID: 27146482)
1. Digoxin use after diagnosis of prostate cancer and survival: a population-based cohort study.
Karasneh RA; Murray LJ; Hughes CM; Cardwell CR
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1099-103. PubMed ID: 27146482
[TBL] [Abstract][Full Text] [Related]
2. Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study.
Karasneh RA; Murray LJ; Mc Menamin ÚC; Hughes CM; Cardwell CR
Breast Cancer Res Treat; 2015 Jun; 151(3):661-9. PubMed ID: 25975954
[TBL] [Abstract][Full Text] [Related]
3. Digoxin use after diagnosis of colorectal cancer and survival: a population-based cohort study.
Karasneh RA; Murray LJ; Hughes CM; Cardwell CR
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1804-7. PubMed ID: 26364159
[TBL] [Abstract][Full Text] [Related]
4. A cohort study of digoxin exposure and mortality in men with prostate cancer.
Flahavan EM; Sharp L; Bennett K; Barron TI
BJU Int; 2014 Feb; 113(2):236-45. PubMed ID: 23937513
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
Hicks BM; Murray LJ; Hughes C; Cardwell CR
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):830-40. PubMed ID: 26017274
[TBL] [Abstract][Full Text] [Related]
6. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial.
Kaapu KJ; Murtola TJ; Määttänen L; Talala K; Taari K; Tammela TL; Auvinen A
Cancer Causes Control; 2016 Feb; 27(2):157-64. PubMed ID: 26573846
[TBL] [Abstract][Full Text] [Related]
8. Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer.
Kaapu KJ; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
Br J Cancer; 2016 Nov; 115(11):1289-1295. PubMed ID: 27755533
[TBL] [Abstract][Full Text] [Related]
9. Statin use after diagnosis of breast cancer and survival: a population-based cohort study.
Cardwell CR; Hicks BM; Hughes C; Murray LJ
Epidemiology; 2015 Jan; 26(1):68-78. PubMed ID: 25304447
[TBL] [Abstract][Full Text] [Related]
10. Use of statins and the risk of death in patients with prostate cancer.
Yu O; Eberg M; Benayoun S; Aprikian A; Batist G; Suissa S; Azoulay L
J Clin Oncol; 2014 Jan; 32(1):5-11. PubMed ID: 24190110
[TBL] [Abstract][Full Text] [Related]
11. Statin use and survival from lung cancer: a population-based cohort study.
Cardwell CR; Mc Menamin Ú; Hughes CM; Murray LJ
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):833-41. PubMed ID: 25934831
[TBL] [Abstract][Full Text] [Related]
12. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.
Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Van den Berg MP; Van Gelder IC;
Heart Rhythm; 2014 Sep; 11(9):1543-50. PubMed ID: 24924587
[TBL] [Abstract][Full Text] [Related]
13. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
[TBL] [Abstract][Full Text] [Related]
14. Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer.
Assayag J; Pollak MN; Azoulay L
Eur J Cancer; 2014 Nov; 50(16):2838-45. PubMed ID: 25204805
[TBL] [Abstract][Full Text] [Related]
15. Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study.
Sessa M; Mascolo A; Andersen MP; Rosano G; Rossi F; Capuano A; Torp-Pedersen C
PLoS One; 2016; 11(7):e0160337. PubMed ID: 27467520
[TBL] [Abstract][Full Text] [Related]
16. Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study.
Mc Menamin ÚC; Cardwell CR; Hughes CM; Murray LJ
Cancer Epidemiol; 2017 Apr; 47():20-27. PubMed ID: 28088656
[TBL] [Abstract][Full Text] [Related]
17. Type 2 diabetes and the risk of mortality among patients with prostate cancer.
Bensimon L; Yin H; Suissa S; Pollak MN; Azoulay L
Cancer Causes Control; 2014 Mar; 25(3):329-38. PubMed ID: 24384808
[TBL] [Abstract][Full Text] [Related]
18. Statin use after colorectal cancer diagnosis and survival: a population-based cohort study.
Cardwell CR; Hicks BM; Hughes C; Murray LJ
J Clin Oncol; 2014 Oct; 32(28):3177-83. PubMed ID: 25092779
[TBL] [Abstract][Full Text] [Related]
19. Statin use and breast cancer survival: a nationwide cohort study in Scotland.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
BMC Cancer; 2016 Aug; 16():600. PubMed ID: 27491389
[TBL] [Abstract][Full Text] [Related]
20. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
